medicines evaluation board
Responsibility for assessing, authorising and for monitoring the safety of human medicinal products lies with a Board consisting of doctors, pharmacists and scientists. This Medicines Evaluation Board (MEB) has autonomous powers to take decisions on the availability of these medicinal products. The MEB is responsible for authorising and monitoring safe and effective medicinal products on the Dutch market and shares responsibility for authorising medicinal products throughout the European Union.
The MEB consists of a chairman and at least nine to a maximum of seventeen other members (doctors, pharmacists and scientists). The chairman and members are appointed by the Minister for Health, Welfare and Sport.
The chairman and members are appointed for a four-year term and can be reappointed for a further four years. The MEB’s operating modalities and responsibilities are laid down in the Dutch Medicines Act (Geneesmiddelenwet).
The members of the Board are supported in their work by the over 220 employees of the MEB Agency. As part of the Ministry of Health, Welfare and Sport, the Agency is responsible for preparing and implementing the MEB’s decisions and for coordinating pharmacovigilance in the Netherlands.
The Agency also performs assessments of veterinary medicines via the Veterinary Medicines Unit and the evaluation of novel foods via the Novel Foods Unit. However, the Board is not responsible for decisions and authorisation regarding veterinary medicinal products and novel foods.
The Veterinary Medicines Unit prepares the decisions for the Veterinary Medicinal Products Authorisation Committee. This Committee advises the Minister for Agriculture, Nature and Food Quality and the Minister for Health, Welfare and Sport, who are responsible for policy and share the political responsibility.
In the Netherlands, the competent authority for assessing Novel Foods is the Ministry of Health, Welfare and Sport. The Ministry then asks the Novel Foods Unit of the MEB Agency to conduct a scientific assessment of the product to determine consumer safety.
You can find agendas and minutes of MEB meetings on the News page in the Human Medicines section.
For more information about a particular MEB member, please click on the name. This will give you more details about the particular member along with a short CV and declaration of interests.
Mandated and authorised officers
The Medicines Evaluation Board (MEB) has appointed and mandated officers, who can decide on behalf of the MEB and are authorised to represent the MEB. Furthermore, the MEB has appointed and authorised officers to perform acts on behalf of the MEB with respect to marketing authorisation applications and other procedures.
Go back »